258 related articles for article (PubMed ID: 23766519)
1. Long-term bioavailability after a single oral or intramuscular administration of 600,000 IU of ergocalciferol or cholecalciferol: implications for treatment and prophylaxis.
Cipriani C; Romagnoli E; Pepe J; Russo S; Carlucci L; Piemonte S; Nieddu L; McMahon DJ; Singh R; Minisola S
J Clin Endocrinol Metab; 2013 Jul; 98(7):2709-15. PubMed ID: 23766519
[TBL] [Abstract][Full Text] [Related]
2. Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol.
Glendenning P; Chew GT; Inderjeeth CA; Taranto M; Fraser WD
Bone; 2013 Oct; 56(2):271-5. PubMed ID: 23792937
[TBL] [Abstract][Full Text] [Related]
3. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
Wetmore JB; Kimber C; Mahnken JD; Stubbs JR
Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190
[TBL] [Abstract][Full Text] [Related]
4. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
Leventis P; Kiely PD
Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184
[TBL] [Abstract][Full Text] [Related]
5. Fortified malted milk drinks containing low-dose ergocalciferol and cholecalciferol do not differ in their capacity to raise serum 25-hydroxyvitamin D concentrations in healthy men and women not exposed to UV-B.
Fisk CM; Theobald HE; Sanders TA
J Nutr; 2012 Jul; 142(7):1286-90. PubMed ID: 22623396
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of vitamin D(2) and D(3) in healthy volunteers, a randomized placebo-controlled trial.
Lehmann U; Hirche F; Stangl GI; Hinz K; Westphal S; Dierkes J
J Clin Endocrinol Metab; 2013 Nov; 98(11):4339-45. PubMed ID: 24001747
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D deficiency and its correction in children with sickle cell anaemia.
Wykes C; Arasaretnam A; O'Driscoll S; Farnham L; Moniz C; Rees DC
Ann Hematol; 2014 Dec; 93(12):2051-6. PubMed ID: 24981689
[TBL] [Abstract][Full Text] [Related]
8. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly.
Romagnoli E; Mascia ML; Cipriani C; Fassino V; Mazzei F; D'Erasmo E; Carnevale V; Scillitani A; Minisola S
J Clin Endocrinol Metab; 2008 Aug; 93(8):3015-20. PubMed ID: 18492750
[TBL] [Abstract][Full Text] [Related]
9. Effects of a 10-day course of a high dose calciferol versus a single mega dose of ergocalciferol in correcting vitamin D deficiency.
Melhem SJ; Aiedeh KM; Hadidi KA
Ann Saudi Med; 2015; 35(1):13-8. PubMed ID: 26142932
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation.
Biancuzzo RM; Clarke N; Reitz RE; Travison TG; Holick MF
J Clin Endocrinol Metab; 2013 Mar; 98(3):973-9. PubMed ID: 23386645
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D-deficiency in the elderly: treatment with ergocalciferol and hydroxylated analogues of vitamin D3.
Shany S; Chaimovitz C; Yagev R; Bercovich M; Lowenthal MN
Isr J Med Sci; 1988 Mar; 24(3):160-3. PubMed ID: 3259568
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of high dose intramuscular or oral cholecalciferol in vitamin D deficient/insufficient elderly.
Tellioglu A; Basaran S; Guzel R; Seydaoglu G
Maturitas; 2012 Aug; 72(4):332-8. PubMed ID: 22613271
[TBL] [Abstract][Full Text] [Related]
13. Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃.
Rossini M; Gatti D; Viapiana O; Fracassi E; Idolazzi L; Zanoni S; Adami S
J Clin Endocrinol Metab; 2012 Apr; 97(4):E622-6. PubMed ID: 22298802
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.
Hiremath GS; Cettomai D; Baynes M; Ratchford JN; Newsome S; Harrison D; Kerr D; Greenberg BM; Calabresi PA
Mult Scler; 2009 Jun; 15(6):735-40. PubMed ID: 19383644
[TBL] [Abstract][Full Text] [Related]
15. The change in plasma 25-hydroxyvitamin D did not differ between breast-fed infants that received a daily supplement of ergocalciferol or cholecalciferol for 3 months.
Gallo S; Phan A; Vanstone CA; Rodd C; Weiler HA
J Nutr; 2013 Feb; 143(2):148-53. PubMed ID: 23256143
[TBL] [Abstract][Full Text] [Related]
16. Serum 24,25-dihydroxyvitamin D
Graeff-Armas LA; Kaufmann M; Lyden E; Jones G
Clin Nutr; 2018 Jun; 37(3):1041-1045. PubMed ID: 28506446
[TBL] [Abstract][Full Text] [Related]
17. Dietary calcium does not interact with vitamin D₃ in terms of determining the response and catabolism of serum 25-hydroxyvitamin D during winter in older adults.
Cashman KD; Hayes A; O'Donovan SM; Zhang JY; Kinsella M; Galvin K; Kiely M; Seamans KM
Am J Clin Nutr; 2014 Jun; 99(6):1414-23. PubMed ID: 24695896
[TBL] [Abstract][Full Text] [Related]
18. Effect of a single oral dose of 600,000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study.
Cipriani C; Romagnoli E; Scillitani A; Chiodini I; Clerico R; Carnevale V; Mascia ML; Battista C; Viti R; Pileri M; Eller-Vainicher C; Minisola S
J Clin Endocrinol Metab; 2010 Oct; 95(10):4771-7. PubMed ID: 20660032
[TBL] [Abstract][Full Text] [Related]
19. 25-Hydroxyvitamin D response to graded vitamin D₃ supplementation among obese adults.
Drincic A; Fuller E; Heaney RP; Armas LA
J Clin Endocrinol Metab; 2013 Dec; 98(12):4845-51. PubMed ID: 24037880
[TBL] [Abstract][Full Text] [Related]
20. Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol.
Glendenning P; Chew GT; Seymour HM; Gillett MJ; Goldswain PR; Inderjeeth CA; Vasikaran SD; Taranto M; Musk AA; Fraser WD
Bone; 2009 Nov; 45(5):870-5. PubMed ID: 19631774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
